The Pharmacokinetics Of Pregabalin Controlled Release Formulation In Fed State Compared To The Controlled Release And Immediate Release Formulations In The Fasted State.

Trial Profile

The Pharmacokinetics Of Pregabalin Controlled Release Formulation In Fed State Compared To The Controlled Release And Immediate Release Formulations In The Fasted State.

Completed
Phase of Trial: Phase I

Latest Information Update: 31 Jul 2014

At a glance

  • Drugs Pregabalin (Primary)
  • Indications Epilepsy; Fibromyalgia; Generalised anxiety disorder; Neuropathic pain
  • Focus Pharmacokinetics
  • Sponsors Pfizer
  • Most Recent Events

    • 30 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 06 May 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top